Search

everythinglearnresearchcommunity

for

Search:↓

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Early treatment of superficial fungal infections in immunocompromised patients is crucial.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

Black women's unique hair characteristics and styling practices can lead to specific scalp conditions, which require early diagnosis and appropriate treatment.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Apremilast improved symptoms in patients with severe skin conditions.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Longer hair loss leads to more severe CCCA; early treatment and avoiding damaging hairstyles help regrowth.

Hair loss in black women needs more research, early intervention, and community education.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

Dupilumab for atopic dermatitis may cause new or worsen existing alopecia areata.

Autoimmune liver diseases are likely linked to certain skin conditions like vitiligo and psoriasis.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Platelet-rich plasma (PRP) is a safe and potentially effective way to treat hair loss, especially when combined with minoxidil.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

The document concludes that eyelash trichomegaly, which is the abnormal growth of eyelashes, can be present from birth, caused by diseases, or result from certain medications.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Consider benefits and risks of new alopecia treatments for safety.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Hair loss is a rare but recognized symptom of pemphigus vulgaris, with patients usually regrowing hair after treatment.

Oral minoxidil effectively treats hair loss, with women needing lower doses (0.25 to 2.5 mg daily) and men needing higher doses (1.25 to 5 mg daily).

The document concludes that understanding dermal papilla cells is key to improving hair regeneration treatments.

The document concludes that clinicians should be aware of common hair and scalp disorders in women of African descent and that more research is needed to develop effective treatments.

Lupus panniculitis of the scalp causes linear hair loss and needs ongoing treatment to prevent recurrence and lupus.

Proper education can prevent traction alopecia in women of color.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.